NEWARK, Del, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global fructosamine test market was valued at around US$ 266.3 million in 2023 and is poised to exhibit a CAGR of 3.8% during the forecast period.

Fructosamine and glycated albumin were independently associated with the risk for incident diabetes, prevalent retinopathy and incident chronic kidney disease, according to researchers. However, these ...

(HealthDay News) – Fructosamine and glycated albumin are markers of glycemic control that may complement hemoglobin A1c (HbA1c) in identifying risk of diabetes and its complications, according to ...

Please provide your email address to receive an email when new articles are posted on . Fructosamine can be a good glycemia screening tool and elevated levels can have a predictive role for ...

MONDAY, Jan. 20, 2014 (HealthDay News) — The glycemic markers fructosamine and glycated albumin may complement hemoglobin A1c in identifying risk for diabetes and its complications, researchers have ...

Fructosamine testing is used to monitor a person’s blood glucose level if they have diabetes mellitus. It is also useful in determining the efficacy of changes in one’s diabetic treatment plan, such ...

MarketsandResearch.biz recently published a well-explored market study titled Global Fructosamine Reagents Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 which attempts ...

Objective—The glycation gap (the difference between measured A1C and the value predicted by regression on fructosamine) is stable and is associated with microvascular complications of diabetes but has ...